Corp-Ethics.com - Report: GSK faces anti-depressant lawsuit

Company	GlaxoSmithKline [Company Info]
	Track this Company (an email will be sent to you everytime a report is filed about this company)

Date	Issue	Title
6th Sep 2004	Other Issue	GSK faces anti-depressant lawsuit

Report

GlaxoSmithKline (GSK) is facing a US lawsuit alleging that it covered up negative research findings on its anti-depressant drug Paxil.

The lawsuits were filed on behalf of children and teenagers who were prescribed Paxil, known as Seroxat in the UK and Europe.

They claim GSK suppressed data showing that Paxil increased suicidal tendencies in young people.

GSK has denied the allegations, and said it would defend itself in court.

The lawsuit is the latest in series of legal battles GSK has had to fight over Paxil, once its best-selling drug.

Earlier this year, claims that some research into Paxil may have been withheld triggered an investigation by New York prosecutor Eliot Spitzer.

Last month, the company paid $2.5m (£1.3m) to settle Mr Spitzer's inquiry.

It also agreed to publish the results of all clinical tests on its drugs since December 2000 on the internet.

The December cut-off date marks the point at which Glaxo Wellcome merged with Smithkline Beecham.

GSK is also fighting separate lawsuits brought by adult Paxil users who claim it caused adverse side-effects.

GSK shares were down 4 pence at £11.49 in early afternoon trade in London.

Other Reports on GlaxoSmithKline
Date	Issue	Company	Report
29th Jan 2007	Questionable Practice	GlaxoSmithKline	GSK hid paxil suicide link
10th Aug 2006	Other Issue	GlaxoSmithKline	Glaxo pays $70m to end price row
29th Mar 2006	Questionable Practice	GlaxoSmithKline	Glaxo agrees US Paxil settlement
18th Mar 2005	Other Issue	GlaxoSmithKline	Glaxo shares dip on factory probe
22nd Sep 2004	Questionable Practice	GlaxoSmithKline	Glaxo drops appeal in Aids drug pricing case
19th May 2004	Other Issue	GlaxoSmithKline	New York sues GlaxoSmithKline
11th May 2004	Fraud Investigation	GlaxoSmithKline	GlaxoSmithKline faces antitrust investigation
22nd Jan 2004	Fraud Investigation	GlaxoSmithKline	$11.1 Million settlement
8th Jan 2004	Questionable Practice	GlaxoSmithKline	£1.5bn Tax Bill
16th Dec 2003	Questionable Practice	GlaxoSmithKline	Glaxo's CEO to scoop 5.7 mln stg a year
25th Jun 2003	Questionable Practice	GlaxoSmithKline	FDA tells Glaxo to pull misleading Flonase ads
25th Jun 2003	Questionable Practice	GlaxoSmithKline	Ordered to pull misleading adverts

Related Reports from the Pharamaceutical Industry
Company	Issue	Report
Merck	Other Issue	Merck fined $9m in Vioxx lawsuit
Pfizer	Questionable Practice	Group sues Pfizer, other drug makers over imports
Merck	Other Issue	Vioxx court case ends in mistrial
Merck	Other Issue	Merck to pay $32m in Vioxx ruling
Merck	Other Issue	Vioxx drug ban hits Merck profits